- Home
- BGFV vs AKTX Comparison
BGFV vs AKTX Comparison
Compare BGFV & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGFV
- AKTX
- Stock Information
- Founded
- BGFV 1955
- AKTX N/A
- Country
- BGFV United States
- AKTX United States
- Employees
- BGFV N/A
- AKTX N/A
- Industry
- BGFV Other Specialty Stores
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- BGFV Consumer Discretionary
- AKTX Health Care
- Exchange
- BGFV Nasdaq
- AKTX Nasdaq
- Market Cap
- BGFV 32.5M
- AKTX 35.7M
- IPO Year
- BGFV N/A
- AKTX N/A
- Fundamental
- Price
- BGFV $1.35
- AKTX $0.79
- Analyst Decision
- BGFV
- AKTX Strong Buy
- Analyst Count
- BGFV 0
- AKTX 2
- Target Price
- BGFV N/A
- AKTX $3.30
- AVG Volume (30 Days)
- BGFV 93.1K
- AKTX 256.6K
- Earning Date
- BGFV 10-28-2025
- AKTX 08-13-2025
- Dividend Yield
- BGFV N/A
- AKTX N/A
- EPS Growth
- BGFV N/A
- AKTX N/A
- EPS
- BGFV N/A
- AKTX N/A
- Revenue
- BGFV $762,758,000.00
- AKTX N/A
- Revenue This Year
- BGFV N/A
- AKTX N/A
- Revenue Next Year
- BGFV N/A
- AKTX N/A
- P/E Ratio
- BGFV N/A
- AKTX N/A
- Revenue Growth
- BGFV N/A
- AKTX N/A
- 52 Week Low
- BGFV $0.80
- AKTX $0.57
- 52 Week High
- BGFV $2.45
- AKTX $3.85
- Technical
- Relative Strength Index (RSI)
- BGFV 30.46
- AKTX 42.84
- Support Level
- BGFV $1.19
- AKTX $0.75
- Resistance Level
- BGFV $1.43
- AKTX $0.89
- Average True Range (ATR)
- BGFV 0.02
- AKTX 0.08
- MACD
- BGFV -0.01
- AKTX 0.01
- Stochastic Oscillator
- BGFV 27.27
- AKTX 70.00
About BGFV Big 5 Sporting Goods Corporation
Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.